(Q96637578)
Statements
2020
For identifying Glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome. (English)
Identifiers
Sitelinks
Wikipedia(4 entries)
- dewiki Joel F. Habener
- enwiki Joel Habener
- frwiki Joel Habener
- zhwiki 喬爾·哈比納